Abstract
Headache after administration of electroconvulsive therapy (ECT) is common, affecting approximately half of patients treated. Post-ECT headache is typically treated with acetaminophen or nonsteroidal anti-inflammatory drugs but occasionally requires agents such as sumatriptan, opioids, or β-blockers. We report on a patient whose severe post-ECT headaches responded completely to methyl salicylate ointment, applied to the area of his temporalis and masseter muscles. Topical methyl salicylate is generally well tolerated and may be a viable option for some patients with post-ECT headache.
MeSH terms
-
Administration, Topical
-
Adult
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Depressive Disorder, Major / complications
-
Depressive Disorder, Major / psychology
-
Depressive Disorder, Major / therapy
-
Electroconvulsive Therapy / adverse effects*
-
Headache / drug therapy*
-
Headache / etiology*
-
Humans
-
Ketorolac / therapeutic use
-
Male
-
Ointments
-
Salicylates / administration & dosage*
-
Salicylates / therapeutic use*
-
Stress Disorders, Post-Traumatic / complications
-
Stress Disorders, Post-Traumatic / psychology
-
Stress Disorders, Post-Traumatic / therapy
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Ointments
-
Salicylates
-
methyl salicylate
-
Ketorolac